Abstract:The combination of ferroptosis, cuproptosis, and chemodynamic therapy (CDT) would be a potential strategy for tumor diagnosis and enhanced treatment. However, the therapeutic effect was severely limited by the lack of specific delivery of catalytic ions and the low Fenton reaction efficiency in tumor microenvironment (TME) with excess glutathione, limited acidity and insufficient endogenous hydrogen peroxide. In this work, p-carboxybenzenesulfonamide (BS), a carbonic anhydrase IX (CA IX) inhibitor, was modified on the surface of generation-5 poly(amidoamine) dendrimer to load copper peroxide nanoparticles, which were complexed with iron (Fe)-tannic acid (TF) networks for targeted magnetic resonance (MR) imaging and enhanced ferroptosis/cuproptosis/CDT by regulating TME. The formed CuO 2 @G5-BS/TF nanocomplexes with an average size of 39.4 nm could be specifically accumulated at tumor site and effectively internalized by metastatic 4T1 cells via the specific interaction between BS and CA IX over-expressed on tumor cells. Meanwhile, the inhibition of CA IX activity could not only decrease the intracellular pH to accelerate Fe 3+ /Cu 2+ release, H 2 O 2 self-supply and Fenton reaction, but also suppress tumor metastasis by alleviating the extracellular acidity in TME. Moreover, the reduction of Fe 3+ /Cu 2+ by intracellular glutathione (GSH) could further amplify ROS generation and enhance CDT efficacy, and the GSH depletion could in turn inhibit GPX-4 mediated antioxidant reaction to induce ferroptosis, resulting in effective therapeutic efficacy. In vivo experimental results demonstrated that CuO 2 @G5-BS/TF could provide better tumor MR imaging, effectively inhibit the growth and metastasis of 4T1 breast tumors, and be metabolized without significant systemic toxicity. Thus, CuO 2 @G5-BS/TF nanocomplexes provided a new approach for targeted MR imaging and enhanced ferroptosis/cuproptosis/CDT of triple-negative breast cancer. Statement of significance Taking the advantage of dendrimer and metal-phenolic system, stable CuO 2 @G5-BS/TF nanocomplexes with an average size of 39.4 nm were synthesized to efficiently load Fe 3+ and CuO 2 nanoparticles for TNBC treatment and MR imaging. CuO 2 @G5-BS/TF nanocomplexes could target tumor cells overexpressing CAIX via the specific binding with BS, and the inhibition of CAIX activity could not only decrease the intracellular pH to accelerate Fe 3+ /Cu 2+ release, H 2 O 2 self-supply and Fenton reaction, but also suppress tumor metastasis by alleviating the extracellular acidity. The reduction of Fe 3+ /Cu 2+ by intracellular GSH could further amplify ·OH generation, and the GSH depletion could in turn inhibit GPX-4 mediated antioxidant reaction to induce ferroptosis, resulting in effective therapeutic efficacy by enhanced ferroptosis/cuproptosis/CDT via tumor microenvironment regulation.

Dendrimer/Copper(II) Complex-Mediated Sirna Delivery Disrupts Lactate Metabolism to Reprogram the Local Immune Microenvironment Against Tumor Growth and Metastasis.

Dendrimer‐Cu(II) Complexes Mediate Enzyme Delivery for Lactate Depletion‐Enhanced Combinational Treatment of Leukemia and Glioma

Polyphenol nanocomplex modulats lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effect

Polymersomes of Biodegradable Polysarcosine-Block-poly(ε-caprolactone)

Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles

Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer

Regulating Tumor Glycometabolism and Immune Microenvironment by Inhibiting Lactate Dehydrogenase with Platinum(IV) Complexes

A Tumor Microenvironment-Responsive Core-Shell Tecto Dendrimer Nanoplatform for Magnetic Resonance Imaging-Guided and Cuproptosis-Promoted Chemo-Chemodynamic Therapy.

Regulating Tumor Glycometabolism and the Immune Microenvironment by Inhibiting Lactate Dehydrogenase with Platinum(iv) Complexes

Dendrimer/metal-phenolic nanocomplexes encapsulating CuO 2 for targeted magnetic resonance imaging and enhanced ferroptosis/cuproptosis/chemodynamic therapy by regulating the tumor microenvironment

Tumor Microenvironment-Activated, Immunomodulatory Nanosheets Loaded with Copper(ii) and 5-FU for Synergistic Chemodynamic Therapy and Chemotherapy.

Tumor‐Selective Nano‐Dispatcher Enforced Cancer Immunotherapeutic Effects via Regulating Lactate Metabolism and Activating Toll‐Like Receptors

Dendrimer/metal-phenolic Nanocomplexes Encapsulating CuO2 for Targeted Magnetic Resonance Imaging and Enhanced Ferroptosis/cuproptosis/chemodynamic Therapy by Regulating the Tumor Microenvironment.

Core-shell Tecto Dendrimers Co-Deliver Drug/gene for Immunomodulation of Macrophages and Dendritic Cells and Checkpoint Blockade-Promoted Breast Cancer Chemoimmunotherapy

Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy

Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy

Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA

Abstract 7255: Peptide-based siRNA delivery for tumor-specific targeting of lactate dehydrogenase C

A Sub-6 Nm MnFe2O4-dichloroacetic Acid Nanocomposite Modulates Tumor Metabolism and Catabolism for Reversing Tumor Immunosuppressive Microenvironment and Boosting Immunotherapy.

Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism

Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy